|
Market Closed -
London S.E.
11:20:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 09-03 | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
| 09-02 | Roche, Treeline Biosciences to Evaluate Combination Therapy for B-cell Lymphomas | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCHE HOLDING AG | Other Pharmaceuticals | 0.00% | 0.00% | -1.29% | +21.72% | -5.86% | 343B |
-
|
-
|
-
|
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
- Charts Roche Holding AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
